Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.22
-0.09 (-1.51%)
At close: Aug 1, 2025, 4:00 PM
6.21
0.00 (-0.08%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Inogen Revenue
Inogen had revenue of $82.28M in the quarter ending March 31, 2025, with 5.45% growth. This brings the company's revenue in the last twelve months to $339.96M, up 5.73% year-over-year. In the year 2024, Inogen had annual revenue of $335.71M with 6.35% growth.
Revenue (ttm)
$339.96M
Revenue Growth
+5.73%
P/S Ratio
0.44
Revenue / Employee
$443,812
Employees
766
Market Cap
166.97M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
INGN News
- 15 days ago - Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 5 weeks ago - Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy - Business Wire
- 2 months ago - Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough - Benzinga
- 3 months ago - Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Inogen Announces First Quarter 2025 Financial Results - Business Wire
- 4 months ago - Inogen To Present at 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 5 months ago - A Volatile Share Price Masks Some Of The Progress At Inogen - Seeking Alpha
- 5 months ago - What's Going On With MedTech Focused Inogen Stock On Wednesday? - Benzinga